Volume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Play/PauseSPACE
Increase Volume
Decrease Volume
Seek Forward
Seek Backward
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Seek %0-9
00:00
00:00
00:00
 

Chapters

Transcript

 

[MUSIC PLAYING]

SPEAKER 1: So the type of viral vectors that you use contains a complementary DNA. Is DNA going to get integrated into the host DNA? Or is DNA going to be transcripted and translated without any integration with the DNA of the host?

SPEAKER 2: Great question. And this really brings up the issue of type of the viruses that we use for the gene therapy strategy. I didn't associate the viral vectors which are being widely used right now in the CNS disorders. Actually, our DNA do not integrate. They remain episomal. So likelihood of having any issues as it relates to insertion and mutagenesis is very, very low.

Other type of vectors based on antiviruses or retroviruses can actually integrate as RNA viruses. And they can undergo a random insertion. So increases the chances for any potential issues as it relates to any mutagenesis.

Video

Transcription, Translation of DNA Contained in Viral Vector

Aristide Merola, MD, PhD, and Krystof Bankiewicz, MD, PhD, discuss how DNA is used during gene therapy sessions.

Related Presenters

Aristide Merola, MD, PhD.

Aristide Merola, MD, PhD

Neurology
Associate Professor of Neurology

View full profile

Krystof Bankiewicz, MD, PhD.

Krystof Bankiewicz, MD, PhD

Neurosurgery
Professor of Neurological Surgery

View full profile

ADVERTISEMENT

Related Videos